nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—type 2 diabetes mellitus	0.306	1	CbGaD
Rizatriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.111	0.285	CbGbCtD
Rizatriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.107	0.273	CbGbCtD
Rizatriptan—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0668	0.171	CbGbCtD
Rizatriptan—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0347	0.0888	CbGbCtD
Rizatriptan—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0273	0.0699	CbGbCtD
Rizatriptan—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0258	0.0661	CbGbCtD
Rizatriptan—CYP1A2—Losartan—type 2 diabetes mellitus	0.0176	0.0451	CbGbCtD
Rizatriptan—Melatonin—MTNR1A—type 2 diabetes mellitus	0.00223	0.392	CrCbGaD
Rizatriptan—Melatonin—MTNR1B—type 2 diabetes mellitus	0.00117	0.206	CrCbGaD
Rizatriptan—Melatonin—CALM1—type 2 diabetes mellitus	0.000718	0.126	CrCbGaD
Rizatriptan—HTR1B—artery—type 2 diabetes mellitus	0.000567	0.155	CbGeAlD
Rizatriptan—HTR1D—artery—type 2 diabetes mellitus	0.000549	0.15	CbGeAlD
Rizatriptan—Zolmitriptan—CYP1A2—type 2 diabetes mellitus	0.000441	0.0775	CrCbGaD
Rizatriptan—MAOA—nerve—type 2 diabetes mellitus	0.000415	0.113	CbGeAlD
Rizatriptan—Almotriptan—CYP2E1—type 2 diabetes mellitus	0.000352	0.0617	CrCbGaD
Rizatriptan—Almotriptan—CYP1A2—type 2 diabetes mellitus	0.000334	0.0587	CrCbGaD
Rizatriptan—Melatonin—CYP1A2—type 2 diabetes mellitus	0.000226	0.0397	CrCbGaD
Rizatriptan—Almotriptan—CYP3A4—type 2 diabetes mellitus	0.000221	0.0389	CrCbGaD
Rizatriptan—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000201	0.0549	CbGeAlD
Rizatriptan—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000197	0.0539	CbGeAlD
Rizatriptan—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000191	0.0521	CbGeAlD
Rizatriptan—HTR1D—kidney—type 2 diabetes mellitus	0.000187	0.051	CbGeAlD
Rizatriptan—MAOA—retina—type 2 diabetes mellitus	0.000172	0.0469	CbGeAlD
Rizatriptan—MAOA—nephron tubule—type 2 diabetes mellitus	0.000162	0.0442	CbGeAlD
Rizatriptan—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000159	0.0435	CbGeAlD
Rizatriptan—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000145	0.0397	CbGeAlD
Rizatriptan—MAOA—kidney—type 2 diabetes mellitus	0.000142	0.0389	CbGeAlD
Rizatriptan—MAOA—pancreas—type 2 diabetes mellitus	0.000141	0.0386	CbGeAlD
Rizatriptan—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000138	0.0378	CbGeAlD
Rizatriptan—MAOA—adipose tissue—type 2 diabetes mellitus	0.000128	0.035	CbGeAlD
Rizatriptan—Cough—Irbesartan—type 2 diabetes mellitus	0.000123	0.000597	CcSEcCtD
Rizatriptan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000597	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000122	0.000592	CcSEcCtD
Rizatriptan—Agitation—Losartan—type 2 diabetes mellitus	0.000122	0.000592	CcSEcCtD
Rizatriptan—Oedema—Metformin—type 2 diabetes mellitus	0.000122	0.000592	CcSEcCtD
Rizatriptan—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000122	0.000592	CcSEcCtD
Rizatriptan—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000122	0.000591	CcSEcCtD
Rizatriptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00059	CcSEcCtD
Rizatriptan—Flushing—Ramipril—type 2 diabetes mellitus	0.000122	0.000589	CcSEcCtD
Rizatriptan—Angioedema—Losartan—type 2 diabetes mellitus	0.000122	0.000589	CcSEcCtD
Rizatriptan—Insomnia—Valsartan—type 2 diabetes mellitus	0.000122	0.000588	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000121	0.000585	CcSEcCtD
Rizatriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000121	0.000584	CcSEcCtD
Rizatriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000121	0.000583	CcSEcCtD
Rizatriptan—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00012	0.000583	CcSEcCtD
Rizatriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000583	CcSEcCtD
Rizatriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000583	CcSEcCtD
Rizatriptan—Shock—Metformin—type 2 diabetes mellitus	0.00012	0.000582	CcSEcCtD
Rizatriptan—Insomnia—Orlistat—type 2 diabetes mellitus	0.00012	0.000581	CcSEcCtD
Rizatriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00012	0.000581	CcSEcCtD
Rizatriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00012	0.000581	CcSEcCtD
Rizatriptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00012	0.000581	CcSEcCtD
Rizatriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00012	0.00058	CcSEcCtD
Rizatriptan—Vertigo—Losartan—type 2 diabetes mellitus	0.00012	0.000579	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00012	0.000579	CcSEcCtD
Rizatriptan—Somnolence—Valsartan—type 2 diabetes mellitus	0.000119	0.000578	CcSEcCtD
Rizatriptan—Syncope—Losartan—type 2 diabetes mellitus	0.000119	0.000578	CcSEcCtD
Rizatriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000119	0.000577	CcSEcCtD
Rizatriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000119	0.000576	CcSEcCtD
Rizatriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000118	0.000572	CcSEcCtD
Rizatriptan—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000118	0.000572	CcSEcCtD
Rizatriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00057	CcSEcCtD
Rizatriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000118	0.00057	CcSEcCtD
Rizatriptan—Palpitations—Losartan—type 2 diabetes mellitus	0.000118	0.000569	CcSEcCtD
Rizatriptan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000117	0.000568	CcSEcCtD
Rizatriptan—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000117	0.000567	CcSEcCtD
Rizatriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000117	0.000566	CcSEcCtD
Rizatriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000566	CcSEcCtD
Rizatriptan—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000117	0.000565	CcSEcCtD
Rizatriptan—Asthenia—Glyburide—type 2 diabetes mellitus	0.000117	0.000565	CcSEcCtD
Rizatriptan—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000117	0.000565	CcSEcCtD
Rizatriptan—Anorexia—Metformin—type 2 diabetes mellitus	0.000117	0.000564	CcSEcCtD
Rizatriptan—Cough—Losartan—type 2 diabetes mellitus	0.000116	0.000562	CcSEcCtD
Rizatriptan—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000116	0.000562	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000116	0.000561	CcSEcCtD
Rizatriptan—Fatigue—Valsartan—type 2 diabetes mellitus	0.000116	0.00056	CcSEcCtD
Rizatriptan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.000559	CcSEcCtD
Rizatriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000116	0.000559	CcSEcCtD
Rizatriptan—Oedema—Irbesartan—type 2 diabetes mellitus	0.000115	0.000559	CcSEcCtD
Rizatriptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000115	0.000559	CcSEcCtD
Rizatriptan—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000115	0.000558	CcSEcCtD
Rizatriptan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000115	0.000557	CcSEcCtD
Rizatriptan—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.000556	CcSEcCtD
Rizatriptan—Constipation—Valsartan—type 2 diabetes mellitus	0.000115	0.000556	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000115	0.000555	CcSEcCtD
Rizatriptan—Fatigue—Orlistat—type 2 diabetes mellitus	0.000114	0.000554	CcSEcCtD
Rizatriptan—Erythema—Ramipril—type 2 diabetes mellitus	0.000114	0.000552	CcSEcCtD
Rizatriptan—Shock—Irbesartan—type 2 diabetes mellitus	0.000114	0.00055	CcSEcCtD
Rizatriptan—Pain—Orlistat—type 2 diabetes mellitus	0.000114	0.000549	CcSEcCtD
Rizatriptan—Myalgia—Losartan—type 2 diabetes mellitus	0.000113	0.000548	CcSEcCtD
Rizatriptan—Arthralgia—Losartan—type 2 diabetes mellitus	0.000113	0.000548	CcSEcCtD
Rizatriptan—Chest pain—Losartan—type 2 diabetes mellitus	0.000113	0.000548	CcSEcCtD
Rizatriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000548	CcSEcCtD
Rizatriptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000113	0.000548	CcSEcCtD
Rizatriptan—Anxiety—Losartan—type 2 diabetes mellitus	0.000113	0.000547	CcSEcCtD
Rizatriptan—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000545	CcSEcCtD
Rizatriptan—Rash—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000543	CcSEcCtD
Rizatriptan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000543	CcSEcCtD
Rizatriptan—Tension—Ramipril—type 2 diabetes mellitus	0.000112	0.000542	CcSEcCtD
Rizatriptan—Discomfort—Losartan—type 2 diabetes mellitus	0.000112	0.000542	CcSEcCtD
Rizatriptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000112	0.000541	CcSEcCtD
Rizatriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000112	0.00054	CcSEcCtD
Rizatriptan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00054	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000111	0.000539	CcSEcCtD
Rizatriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000111	0.000539	CcSEcCtD
Rizatriptan—Nervousness—Ramipril—type 2 diabetes mellitus	0.000111	0.000536	CcSEcCtD
Rizatriptan—Dry mouth—Losartan—type 2 diabetes mellitus	0.000111	0.000536	CcSEcCtD
Rizatriptan—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000533	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00011	0.000532	CcSEcCtD
Rizatriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00011	0.000532	CcSEcCtD
Rizatriptan—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00011	0.000531	CcSEcCtD
Rizatriptan—Confusional state—Losartan—type 2 diabetes mellitus	0.00011	0.00053	CcSEcCtD
Rizatriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000109	0.000529	CcSEcCtD
Rizatriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000109	0.000528	CcSEcCtD
Rizatriptan—Somnolence—Metformin—type 2 diabetes mellitus	0.000109	0.000526	CcSEcCtD
Rizatriptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000109	0.000526	CcSEcCtD
Rizatriptan—Oedema—Losartan—type 2 diabetes mellitus	0.000109	0.000526	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000109	0.000525	CcSEcCtD
Rizatriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000108	0.000521	CcSEcCtD
Rizatriptan—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000108	0.000521	CcSEcCtD
Rizatriptan—Tremor—Ramipril—type 2 diabetes mellitus	0.000107	0.000518	CcSEcCtD
Rizatriptan—Shock—Losartan—type 2 diabetes mellitus	0.000107	0.000517	CcSEcCtD
Rizatriptan—Urticaria—Valsartan—type 2 diabetes mellitus	0.000107	0.000516	CcSEcCtD
Rizatriptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000107	0.000516	CcSEcCtD
Rizatriptan—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000106	0.000515	CcSEcCtD
Rizatriptan—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000106	0.000514	CcSEcCtD
Rizatriptan—Tachycardia—Losartan—type 2 diabetes mellitus	0.000106	0.000513	CcSEcCtD
Rizatriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000512	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000106	0.000511	CcSEcCtD
Rizatriptan—Fatigue—Metformin—type 2 diabetes mellitus	0.000105	0.00051	CcSEcCtD
Rizatriptan—Urticaria—Orlistat—type 2 diabetes mellitus	0.000105	0.00051	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000105	0.000509	CcSEcCtD
Rizatriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000105	0.000508	CcSEcCtD
Rizatriptan—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000105	0.000508	CcSEcCtD
Rizatriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000105	0.000508	CcSEcCtD
Rizatriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000105	0.000508	CcSEcCtD
Rizatriptan—Agitation—Ramipril—type 2 diabetes mellitus	0.000105	0.000508	CcSEcCtD
Rizatriptan—Constipation—Metformin—type 2 diabetes mellitus	0.000105	0.000506	CcSEcCtD
Rizatriptan—Angioedema—Ramipril—type 2 diabetes mellitus	0.000104	0.000505	CcSEcCtD
Rizatriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000502	CcSEcCtD
Rizatriptan—Anorexia—Losartan—type 2 diabetes mellitus	0.000104	0.000501	CcSEcCtD
Rizatriptan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000104	0.000501	CcSEcCtD
Rizatriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000103	0.000501	CcSEcCtD
Rizatriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000103	0.000498	CcSEcCtD
Rizatriptan—Rash—Glyburide—type 2 diabetes mellitus	0.000103	0.000497	CcSEcCtD
Rizatriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000103	0.000497	CcSEcCtD
Rizatriptan—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000103	0.000496	CcSEcCtD
Rizatriptan—Vertigo—Ramipril—type 2 diabetes mellitus	0.000103	0.000496	CcSEcCtD
Rizatriptan—Syncope—Ramipril—type 2 diabetes mellitus	0.000102	0.000495	CcSEcCtD
Rizatriptan—Headache—Glyburide—type 2 diabetes mellitus	0.000102	0.000494	CcSEcCtD
Rizatriptan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000492	CcSEcCtD
Rizatriptan—Palpitations—Ramipril—type 2 diabetes mellitus	0.000101	0.000488	CcSEcCtD
Rizatriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000101	0.000488	CcSEcCtD
Rizatriptan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.0001	0.000486	CcSEcCtD
Rizatriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.0001	0.000485	CcSEcCtD
Rizatriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.0001	0.000484	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.0001	0.000484	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.97e-05	0.000482	CcSEcCtD
Rizatriptan—Cough—Ramipril—type 2 diabetes mellitus	9.96e-05	0.000482	CcSEcCtD
Rizatriptan—Fatigue—Irbesartan—type 2 diabetes mellitus	9.95e-05	0.000482	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.9e-05	0.000479	CcSEcCtD
Rizatriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000479	CcSEcCtD
Rizatriptan—Convulsion—Ramipril—type 2 diabetes mellitus	9.89e-05	0.000479	CcSEcCtD
Rizatriptan—Constipation—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000478	CcSEcCtD
Rizatriptan—Pain—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000478	CcSEcCtD
Rizatriptan—Insomnia—Losartan—type 2 diabetes mellitus	9.83e-05	0.000476	CcSEcCtD
Rizatriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000473	CcSEcCtD
Rizatriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	9.76e-05	0.000472	CcSEcCtD
Rizatriptan—Urticaria—Metformin—type 2 diabetes mellitus	9.72e-05	0.00047	CcSEcCtD
Rizatriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	9.72e-05	0.00047	CcSEcCtD
Rizatriptan—Chest pain—Ramipril—type 2 diabetes mellitus	9.72e-05	0.00047	CcSEcCtD
Rizatriptan—Myalgia—Ramipril—type 2 diabetes mellitus	9.72e-05	0.00047	CcSEcCtD
Rizatriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	9.69e-05	0.000469	CcSEcCtD
Rizatriptan—Anxiety—Ramipril—type 2 diabetes mellitus	9.69e-05	0.000469	CcSEcCtD
Rizatriptan—Nausea—Glyburide—type 2 diabetes mellitus	9.67e-05	0.000468	CcSEcCtD
Rizatriptan—Abdominal pain—Metformin—type 2 diabetes mellitus	9.67e-05	0.000468	CcSEcCtD
Rizatriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	9.67e-05	0.000468	CcSEcCtD
Rizatriptan—Somnolence—Losartan—type 2 diabetes mellitus	9.66e-05	0.000467	CcSEcCtD
Rizatriptan—Asthenia—Valsartan—type 2 diabetes mellitus	9.64e-05	0.000466	CcSEcCtD
Rizatriptan—Discomfort—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000465	CcSEcCtD
Rizatriptan—Dyspepsia—Losartan—type 2 diabetes mellitus	9.56e-05	0.000463	CcSEcCtD
Rizatriptan—Asthenia—Orlistat—type 2 diabetes mellitus	9.53e-05	0.000461	CcSEcCtD
Rizatriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.00046	CcSEcCtD
Rizatriptan—Pruritus—Valsartan—type 2 diabetes mellitus	9.51e-05	0.00046	CcSEcCtD
Rizatriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	9.51e-05	0.00046	CcSEcCtD
Rizatriptan—Decreased appetite—Losartan—type 2 diabetes mellitus	9.45e-05	0.000457	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000457	CcSEcCtD
Rizatriptan—Confusional state—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000455	CcSEcCtD
Rizatriptan—Pruritus—Orlistat—type 2 diabetes mellitus	9.39e-05	0.000454	CcSEcCtD
Rizatriptan—Fatigue—Losartan—type 2 diabetes mellitus	9.37e-05	0.000453	CcSEcCtD
Rizatriptan—Oedema—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000451	CcSEcCtD
Rizatriptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000451	CcSEcCtD
Rizatriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	9.3e-05	0.00045	CcSEcCtD
Rizatriptan—Pain—Losartan—type 2 diabetes mellitus	9.29e-05	0.00045	CcSEcCtD
Rizatriptan—Constipation—Losartan—type 2 diabetes mellitus	9.29e-05	0.00045	CcSEcCtD
Rizatriptan—Rash—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000446	CcSEcCtD
Rizatriptan—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.21e-05	0.000446	CcSEcCtD
Rizatriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.19e-05	0.000445	CcSEcCtD
Rizatriptan—Urticaria—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000444	CcSEcCtD
Rizatriptan—Shock—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000444	CcSEcCtD
Rizatriptan—Headache—Gliclazide—type 2 diabetes mellitus	9.16e-05	0.000443	CcSEcCtD
Rizatriptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000442	CcSEcCtD
Rizatriptan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000442	CcSEcCtD
Rizatriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000442	CcSEcCtD
Rizatriptan—Tachycardia—Ramipril—type 2 diabetes mellitus	9.09e-05	0.00044	CcSEcCtD
Rizatriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.08e-05	0.000439	CcSEcCtD
Rizatriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000436	CcSEcCtD
Rizatriptan—MAOA—liver—type 2 diabetes mellitus	8.98e-05	0.0246	CbGeAlD
Rizatriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.95e-05	0.000433	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.89e-05	0.00043	CcSEcCtD
Rizatriptan—Dizziness—Valsartan—type 2 diabetes mellitus	8.88e-05	0.00043	CcSEcCtD
Rizatriptan—Anorexia—Ramipril—type 2 diabetes mellitus	8.88e-05	0.00043	CcSEcCtD
Rizatriptan—Dizziness—Orlistat—type 2 diabetes mellitus	8.78e-05	0.000425	CcSEcCtD
Rizatriptan—Asthenia—Metformin—type 2 diabetes mellitus	8.78e-05	0.000425	CcSEcCtD
Rizatriptan—Nausea—Gliclazide—type 2 diabetes mellitus	8.69e-05	0.00042	CcSEcCtD
Rizatriptan—Pruritus—Metformin—type 2 diabetes mellitus	8.66e-05	0.000419	CcSEcCtD
Rizatriptan—Urticaria—Losartan—type 2 diabetes mellitus	8.63e-05	0.000418	CcSEcCtD
Rizatriptan—Abdominal pain—Losartan—type 2 diabetes mellitus	8.59e-05	0.000416	CcSEcCtD
Rizatriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	8.59e-05	0.000416	CcSEcCtD
Rizatriptan—Vomiting—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000413	CcSEcCtD
Rizatriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000412	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000411	CcSEcCtD
Rizatriptan—Rash—Valsartan—type 2 diabetes mellitus	8.47e-05	0.00041	CcSEcCtD
Rizatriptan—Dermatitis—Valsartan—type 2 diabetes mellitus	8.46e-05	0.000409	CcSEcCtD
Rizatriptan—Vomiting—Orlistat—type 2 diabetes mellitus	8.44e-05	0.000408	CcSEcCtD
Rizatriptan—Insomnia—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000408	CcSEcCtD
Rizatriptan—Headache—Valsartan—type 2 diabetes mellitus	8.42e-05	0.000407	CcSEcCtD
Rizatriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	8.37e-05	0.000405	CcSEcCtD
Rizatriptan—Rash—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000405	CcSEcCtD
Rizatriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000405	CcSEcCtD
Rizatriptan—Dermatitis—Orlistat—type 2 diabetes mellitus	8.36e-05	0.000405	CcSEcCtD
Rizatriptan—Headache—Orlistat—type 2 diabetes mellitus	8.32e-05	0.000402	CcSEcCtD
Rizatriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000402	CcSEcCtD
Rizatriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000401	CcSEcCtD
Rizatriptan—Somnolence—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000401	CcSEcCtD
Rizatriptan—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000397	CcSEcCtD
Rizatriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000395	CcSEcCtD
Rizatriptan—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000392	CcSEcCtD
Rizatriptan—Dizziness—Metformin—type 2 diabetes mellitus	8.09e-05	0.000391	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000389	CcSEcCtD
Rizatriptan—Fatigue—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000389	CcSEcCtD
Rizatriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.01e-05	0.000387	CcSEcCtD
Rizatriptan—Nausea—Valsartan—type 2 diabetes mellitus	7.98e-05	0.000386	CcSEcCtD
Rizatriptan—Constipation—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000385	CcSEcCtD
Rizatriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000382	CcSEcCtD
Rizatriptan—Nausea—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000382	CcSEcCtD
Rizatriptan—Asthenia—Losartan—type 2 diabetes mellitus	7.8e-05	0.000377	CcSEcCtD
Rizatriptan—Vomiting—Metformin—type 2 diabetes mellitus	7.78e-05	0.000376	CcSEcCtD
Rizatriptan—Rash—Metformin—type 2 diabetes mellitus	7.71e-05	0.000373	CcSEcCtD
Rizatriptan—Dermatitis—Metformin—type 2 diabetes mellitus	7.71e-05	0.000373	CcSEcCtD
Rizatriptan—Pruritus—Losartan—type 2 diabetes mellitus	7.69e-05	0.000372	CcSEcCtD
Rizatriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000371	CcSEcCtD
Rizatriptan—Headache—Metformin—type 2 diabetes mellitus	7.66e-05	0.000371	CcSEcCtD
Rizatriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000369	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000369	CcSEcCtD
Rizatriptan—CYP1A2—liver—type 2 diabetes mellitus	7.49e-05	0.0205	CbGeAlD
Rizatriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	7.43e-05	0.00036	CcSEcCtD
Rizatriptan—Urticaria—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000358	CcSEcCtD
Rizatriptan—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000356	CcSEcCtD
Rizatriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000356	CcSEcCtD
Rizatriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000355	CcSEcCtD
Rizatriptan—Rash—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000352	CcSEcCtD
Rizatriptan—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000352	CcSEcCtD
Rizatriptan—Nausea—Metformin—type 2 diabetes mellitus	7.27e-05	0.000352	CcSEcCtD
Rizatriptan—Headache—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.00035	CcSEcCtD
Rizatriptan—Dizziness—Losartan—type 2 diabetes mellitus	7.19e-05	0.000348	CcSEcCtD
Rizatriptan—Vomiting—Losartan—type 2 diabetes mellitus	6.91e-05	0.000334	CcSEcCtD
Rizatriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000332	CcSEcCtD
Rizatriptan—Nausea—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000332	CcSEcCtD
Rizatriptan—Rash—Losartan—type 2 diabetes mellitus	6.85e-05	0.000331	CcSEcCtD
Rizatriptan—Dermatitis—Losartan—type 2 diabetes mellitus	6.84e-05	0.000331	CcSEcCtD
Rizatriptan—Headache—Losartan—type 2 diabetes mellitus	6.81e-05	0.000329	CcSEcCtD
Rizatriptan—Asthenia—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000323	CcSEcCtD
Rizatriptan—Pruritus—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000319	CcSEcCtD
Rizatriptan—Nausea—Losartan—type 2 diabetes mellitus	6.45e-05	0.000312	CcSEcCtD
Rizatriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000308	CcSEcCtD
Rizatriptan—Dizziness—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000298	CcSEcCtD
Rizatriptan—Vomiting—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000287	CcSEcCtD
Rizatriptan—Rash—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000284	CcSEcCtD
Rizatriptan—Dermatitis—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000284	CcSEcCtD
Rizatriptan—Headache—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000282	CcSEcCtD
Rizatriptan—Nausea—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000268	CcSEcCtD
Rizatriptan—HTR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.27e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.26e-05	0.000143	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.26e-05	0.000142	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.26e-05	0.000142	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.26e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.26e-05	0.000142	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—LPL—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOB—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.25e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.25e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.24e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.24e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.24e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.23e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.23e-05	0.000139	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ADCY5—type 2 diabetes mellitus	1.23e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.23e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.22e-05	0.000139	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GPX1—type 2 diabetes mellitus	1.22e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.22e-05	0.000138	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.21e-05	0.000137	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.21e-05	0.000137	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.2e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LPL—type 2 diabetes mellitus	1.19e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.19e-05	0.000135	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CD36—type 2 diabetes mellitus	1.19e-05	0.000135	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPP2CA—type 2 diabetes mellitus	1.18e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.17e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.17e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.17e-05	0.000132	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.17e-05	0.000132	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.16e-05	0.000131	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.16e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.15e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.15e-05	0.00013	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.14e-05	0.00013	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.14e-05	0.000129	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.14e-05	0.000129	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.13e-05	0.000129	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.13e-05	0.000129	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	1.13e-05	0.000128	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.12e-05	0.000127	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.12e-05	0.000127	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.12e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.12e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.12e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.11e-05	0.000126	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	1.11e-05	0.000125	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RELA—type 2 diabetes mellitus	1.1e-05	0.000125	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.1e-05	0.000125	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.1e-05	0.000124	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.09e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.08e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—C3—type 2 diabetes mellitus	1.07e-05	0.000122	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AGT—type 2 diabetes mellitus	1.07e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.06e-05	0.00012	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.05e-05	0.000119	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	1.05e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.05e-05	0.000119	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—type 2 diabetes mellitus	1.05e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.04e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.04e-05	0.000118	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	1.04e-05	0.000118	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.04e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.03e-05	0.000116	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.02e-05	0.000116	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGT—type 2 diabetes mellitus	1.02e-05	0.000116	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.01e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	1e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	1e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—type 2 diabetes mellitus	1e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—type 2 diabetes mellitus	1e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	1e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.95e-06	0.000113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.89e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.89e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.87e-06	0.000112	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.87e-06	0.000112	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.86e-06	0.000112	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.83e-06	0.000111	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	9.8e-06	0.000111	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	9.8e-06	0.000111	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.78e-06	0.000111	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.69e-06	0.00011	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	9.65e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.65e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.61e-06	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.56e-06	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	9.53e-06	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	9.53e-06	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	9.53e-06	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	9.53e-06	0.000108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.47e-06	0.000107	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.44e-06	0.000107	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.4e-06	0.000107	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	9.33e-06	0.000106	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.31e-06	0.000105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.29e-06	0.000105	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.24e-06	0.000105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.18e-06	0.000104	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.16e-06	0.000104	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	9.15e-06	0.000104	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	9.14e-06	0.000104	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.12e-06	0.000103	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—INS—type 2 diabetes mellitus	8.97e-06	0.000102	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.93e-06	0.000101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	8.9e-06	0.000101	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.88e-06	0.000101	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.74e-06	9.9e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.72e-06	9.88e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.7e-06	9.85e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SRC—type 2 diabetes mellitus	8.67e-06	9.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.6e-06	9.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INS—type 2 diabetes mellitus	8.55e-06	9.69e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	8.49e-06	9.62e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.45e-06	9.57e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.41e-06	9.53e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	8.37e-06	9.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.35e-06	9.47e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.27e-06	9.37e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.26e-06	9.36e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.24e-06	9.33e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.23e-06	9.32e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—type 2 diabetes mellitus	8.22e-06	9.32e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.2e-06	9.29e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.1e-06	9.17e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.09e-06	9.17e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.06e-06	9.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	8.02e-06	9.08e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.93e-06	8.98e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	7.87e-06	8.91e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	7.87e-06	8.91e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.85e-06	8.9e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.77e-06	8.8e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.77e-06	8.8e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.75e-06	8.78e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.69e-06	8.71e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.65e-06	8.66e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.63e-06	8.64e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.62e-06	8.63e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.62e-06	8.63e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.6e-06	8.61e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.57e-06	8.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.57e-06	8.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.57e-06	8.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.57e-06	8.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	7.52e-06	8.52e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.5e-06	8.49e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.5e-06	8.49e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.49e-06	8.49e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.46e-06	8.46e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.46e-06	8.46e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	7.39e-06	8.37e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.38e-06	8.36e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.34e-06	8.32e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.34e-06	8.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	7.3e-06	8.28e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	7.19e-06	8.15e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	7.06e-06	7.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.04e-06	7.97e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	6.91e-06	7.83e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.81e-06	7.72e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.79e-06	7.69e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.79e-06	7.69e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.79e-06	7.69e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.67e-06	7.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.66e-06	7.54e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.61e-06	7.48e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.51e-06	7.38e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.46e-06	7.32e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.42e-06	7.28e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.38e-06	7.22e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.36e-06	7.21e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.32e-06	7.16e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.29e-06	7.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.27e-06	7.11e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.23e-06	7.06e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.21e-06	7.04e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.19e-06	7.01e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.17e-06	6.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.16e-06	6.98e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.14e-06	6.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.14e-06	6.95e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.01e-06	6.81e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.99e-06	6.79e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.96e-06	6.75e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.95e-06	6.74e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.89e-06	6.67e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.89e-06	6.67e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.89e-06	6.67e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.86e-06	6.64e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—type 2 diabetes mellitus	5.84e-06	6.62e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.83e-06	6.61e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.83e-06	6.6e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.71e-06	6.47e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.59e-06	6.34e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.59e-06	6.34e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	5.54e-06	6.28e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.43e-06	6.15e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.4e-06	6.12e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.39e-06	6.11e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.29e-06	5.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.26e-06	5.96e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.07e-06	5.75e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.07e-06	5.75e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.05e-06	5.72e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.98e-06	5.65e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.96e-06	5.62e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.86e-06	5.51e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.85e-06	5.5e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.84e-06	5.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.79e-06	5.43e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.76e-06	5.39e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.75e-06	5.38e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.72e-06	5.34e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.71e-06	5.33e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.62e-06	5.23e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.52e-06	5.12e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.51e-06	5.11e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.49e-06	5.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.44e-06	5.03e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.39e-06	4.97e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.35e-06	4.93e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.33e-06	4.91e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.16e-06	4.71e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.14e-06	4.69e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.08e-06	4.62e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.03e-06	4.56e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.95e-06	4.48e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.89e-06	4.4e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.87e-06	4.39e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.83e-06	4.34e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	3.74e-06	4.23e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.7e-06	4.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.66e-06	4.14e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.63e-06	4.11e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	3.62e-06	4.1e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.45e-06	3.9e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.37e-06	3.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.37e-06	3.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.31e-06	3.75e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.03e-06	3.44e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.9e-06	3.29e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.9e-06	3.29e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.79e-06	3.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.65e-06	3.01e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.57e-06	2.91e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
